Fibrinolysis Resistance in Infection and Trauma

Abroad (travel likely)Recruiting

Conditions

Sepsis and Septic Shock · Trauma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Canberra hospital (ICU), Canberra, Australian Capital Territory, Australia
Contact: Study coordinator (Philip Crispin, MBBS(Hons), FRACP, FRCPA) · philip.crispin@act.gov.au · + 61251240000
Contact: Study coordinator (Sean W Chan) · seanweng.chan@act.gov.au · + 61251240000
Liverpool Hospital (ICU), Liverpool, New South Wales, Australia
Contact: Study coordinator (Lucy Coupland, Nurs Cert, BSci (hons), PhD) · lucy.coupland@health.nsw.gov.au · + 61419723330
Contact: Study coordinator (Eurwin Suryana, BMedSci (hons), PhD) · eurwin.suryana@health.nsw.gov.au · + 61415148742
Macquarie University Hospital (ICU), Macquarie, New South Wales, Australia
Contact: Study coordinator (Anders Aneman, MD, PhD, EDIC, FCICM) · anders.aneman@health.nsw.gov.au · + 61427915693
Royal North Shore Hospital (ICU), St Leonards, New South Wales, Australia
Contact: Study coordinator (Pierre Janin) · pierre.janin@health.nsw.gov.au · + 61299267111

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Comparative Efficacy and Safety of Propofol-Ketamine Combination Versus Propofol Monotherapy in Geriatric Patients Under Invasive Ventilation

The Critically Ill Patient is Requiring Intubation · Septic Shock · Pneumonia

Abroad (travel likely)RecruitingPHASE3

Cairo, Egypt

Albumin and Crystalloid Administration in Septic Shock

Septic Shock

Abroad (travel likely)RecruitingPHASE4

Seoul, South Korea

ARTICE® Real Data Collection & Observational Trial, Phase 4 Study

Sepsis · Septic Shock · Immunoparalysis in Septic Shock

Abroad (travel likely)Recruiting

Magdeburg, Germany · Minden, Germany

BioMArkeRs of INflammation, Infection, and Immunity in the Critical Area (MARINA): the Use of Inflammatory and Immunity Biomarkers as Early Predictors of Clinical Severity, Organ Damage, Response to Treatment, and Infectious Complications in Patients Admitted to the Critical Care Area.

Septic Shock · Immunocompromised Patients

Abroad (travel likely)Recruiting

Torino, Italy